Kim Yancey, M.D. Titles and Appointments Professor School Medical School Department Dermatology You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Dr. Kim B. Yancey, M.D., is Professor in the Department of Dermatology at UT Southwestern Medical Center in Dallas. A summa cum laude graduate and valedictorian of the University of Georgia, he earned his medical degree from the Medical College of Georgia, where he was inducted into Alpha Omega Alpha. He completed his dermatology residency at the Medical College of Georgia, followed by a postdoctoral fellowship in immunodermatology at the National Cancer Institute, NIH. Dr. Yancey is board-certified by the American Board of Dermatology and holds special competence in dermatologic and diagnostic laboratory immunology. His academic career began at the Uniformed Services University of the Health Sciences, where he rose to Associate Professor and served as Acting Chair. He later joined the NIH as a tenured Senior Investigator, where his research focused on keratinocyte adhesion and the mechanisms underlying autoimmune and inherited blistering diseases. From 2001 to 2006, he served as Professor and Chair of the Department of Dermatology at the Medical College of Wisconsin. In 2007, he was appointed Professor and Chair of the Department of Dermatology at UT Southwestern, a position he held for over a decade. During his tenure, he oversaw major advancements in clinical care, education, and research within the department. Dr. Yancey is a member of several prestigious organizations, including the American Society for Clinical Investigation, Society for Investigative Dermatology, American Academy of Dermatology, and the American Dermatological Association. He has held leadership roles with the American Board of Dermatology, the Society for Investigative Dermatology, and the Dermatology Foundation. A recipient of the American Academy of Dermatology’s Marion Sulzberger Award, Dr. Yancey has authored numerous scientific publications and presented widely at national and international conferences. His research has received continuous NIH support for over 20 years. Education Medical School Medical College of Georgia/Georgia Regents University (1978) Internship Medical College of Georgia (1979), Internal Medicine Residency Medical College of Georgia (1981), Dermatology Other Post Graduate Training National Institutes of Health (1982) Fellowship National Institutes of Health Clinical Center (1985), Immunodermatology Research Interest Animal models of skin disease Autoimmune blistering diseases Inherited blistering diseases (i.e., epidermolysis bullosa) Publications Featured Publications The pathophysiology of autoimmune blistering diseases. Yancey, K.B. J. Clin. Invest. 2005 115 825-828 Revertant mosaicism: partial correction of a germline mutation in COL17A1 by a frame restoring mutation. Darling, T.N., Yee, C., Bauer, J.W., Hintner, H., Yancey, K.B. J. Clin. Invest. 1999 103 1371-1377 Autoreactive CD4+ T-cell responses to the extracellular domain of bullous pemphigoid antigen 2 (BPAG2) in patients with bullous pemphigoid. Budinger, L., Borradori, L., Yee, C., Merk, H.F., Yancey, K.B., Hertl, M. J. Clin. Invest. 1998 102 2082-2089 Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. Lazarova, Z., Yee, C., Darling, T., Briggaman, R.A., Yancey, K.B. J. Clin. Invest. 1996 98 1509-1518 Epiligrin, the major human keratinocye intergrin ligand, is the target of disease in both an acquired autoimmune and an inherited subepidermal blistering skin disease. Domloge-Hultsch, N., Gammon, W.R., Briggaman, R.A., Gil, S.G., Carter, W.G., Yancey, K.B. J. Clin. Invest. 1992 90 1628-1633 Hair follicle stem cells provide a functional niche for melanocyte stem cells. Tanimura, S., Tadokoro, Y., Inomata, K., Binh, N.T., Nishie, W., Yamazaki, S., Nakauchi, H., Tanaka, Y., McMillan, J.R., Sawamura, D., Yancey, K., Shimizu, H., Nishimura, E.K. Cell Stem Cell 2011 8 177-187 Sequential intramolecular epitope spreading of humoral responses to human BPAG2 in a transgenic model. Di Zenzo, G., Calabresi, V., Olasz, E.O., Zambruno, G., Yancey, K.B. J. Invest. Dermatol. 2010 130 1040-1047 Transient Anti-CD40L Co-Stimulation Blockade Prevents Immune Responses against Human Bullous Pemphigoid Antigen 2: Implications for Gene Therapy. Lanschuetzer, C.M., Olasz, E.B., Lazarova, Z., Yancey, K.B. J. Invest. Dermatol. 2009 129 1203-1207 Humanization of autoantigen. Nishie, W., Sawamura, D., Goto, M., Ito, K., Shibaki, A., McMillian, J.R., Sakai, K., Nakamura, H., Olasz, E., Yancey, K.B., Akiyama, M., Shimizu H. Nature Medicine 2007 13 378-383 Human bullous pemphigoid antigen 2 in transgenic skin elicits specific IgG in wild type mice. Olasz, E., Roh, J.Y., Yee, C., Arita, K., Akiyama, M., Shimizu, H., Vogel, J.C., Yancey, K.B. J. Invest. Dermatol. 2007 127 2807-2817 Results 1-10 of 10 1 Honors & Awards Board of Directors, Association of Professors of Dermatology (2015-2018) Board of Directors, Dermatology Foundation (2008-2019) Board of Directors, Society for Investigative Dermatology (2004-2009) Deputy Editor, Journal of Investigative Dermatology (2007-2010) Director, American Board of Dermatology (1997-2005) President, Dermatology Foundation (2017-2019) President, Society for Investigative Dermatology (2011-2012) Sulzberger Award and Lecture, American Academy of Dermatology (2007) Vice President, American Board of Dermatology (2005) Professional Associations/Affiliations American Academy of Dermatology American Association for the Advancement of Science American Dermatological Association American Society for Clinical Investigation Association of Professors of Dermatology Dermatology Foundation Society for Investigative Dermatology
